Syntactx, Now Part of NAMSA Information

Summary

Syntactx, Now Part of NAMSA is a private company that has been in the industry for 16 years. The company currently specializes in the Research, Biotechnology, Medical Research & Laboratories areas. The position of the President & CEO is occupied by Kenneth Ouriel. Its headquarters is located at New York, New York, USA. The number of employees ranges from 25 to 100. The annual revenue of Syntactx, Now Part of NAMSA varies between 5.0M and 25M. Total funding of the company - $1M. To connect with Syntactx, Now Part of NAMSA employee register on SignalHire.

Organization Website	syntactx.com
Social Links
Phone Number	+1 212 228 9000
Industries	R&D
Headquarters Location	4 World Trade Center, New York, NY, 10006 US
Employees Size	100-200 employees
Specialties	Medical Writing, Site Monitoring, Electronic Data Capture, SAS Programming, Safety, CEC and DSMB Oversight, Data Analysis and Statistics, Site Selection, Contracting, and Management, Pharmaceuticals, BIMO Audit, Clinical Evaluation Reports, Imaging Core Laboratory, FDA Panel Prep, Medical and Combination Devices, Regulatory Submissions, PMA Submissions, Trial Design, Global Regulatory Strategy, Post Market Studies, Investigator-Initiated Research
DMA Code	New York Metropolitan Area
Founded	2010
Estimated Annual Revenue	$5.0M - 25M
Operating Status	Acquired